biotech · Malignant Glioma · Prostate Cancer · CADL
Candel Therapeutics
Candel Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US HQ
1999 Founded
82 Employees
Public company Type
CADL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US
- Founded
- 1999
- Employees
- 82
- Programs
- 12
- Drugs
- 4
- Patents
- 0
Candel Therapeutics patents
0 pharmaceutical patents indexed for Candel Therapeutics. 0 expire within 24 months.
Candel Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Candel Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Candel Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.